LOG IN

IShares NASDAQ US Biotechnology UCITS ETF

Versiunea din 18 noiembrie 2024 05:35, autor: 127.0.0.1 (discuție) (The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).)
(dif) ← Versiunea anterioară | Versiunea curentă (dif) | Versiunea următoare → (dif)

Pagina dedicata companiei iShares NASDAQ US Biotechnology UCITS ETF listata cu simbolul DE.2B70

Descriere companieModificare

The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease. The dividends in the fund are reinvested (accumulating).

The total expense ratio amounts to 0.35% p.a.. The fund replicates the performance of the underlying index by buying a selection of the most relevant index constituents (sampling technique). The iShares Nasdaq US Biotechnology UCITS ETF has 322m GBP assets under management. The ETF is older than 3 years and is domiciled in Ireland.

Grafic actiuni companieModificare

Ultimele stiri despre iShares NASDAQ US Biotechnology UCITS ETF (DE.2B70)Modificare

Adus de la „https://wiki.tradeville.ro/index.php?title=IShares_NASDAQ_US_Biotechnology_UCITS_ETF&oldid=528877”